A Comparison of AmBisome(®) to Amphotericin B for Treatment of Systemic Candidiasis in Very Low Birth Weight Infants

PURPOSE: Amphotericin B is considered the treatment of choice for systemic candidiasis, but adverse effects may limit its use. An alternative option for the treatment of candidiasis includes lipid preparations of amphotericin B. This study investigated the safety and efficacy of AmBisome(®), a lipid...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Ga Won, Koo, Soo Hyun, Lee, Jang Hoon, Hwang, Jong Hee, Kim, Sung Shin, Lee, Eun Kyung, Chang, Wook, Chang, Yun Sil, Park, Won Soon
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2007
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628045/
https://www.ncbi.nlm.nih.gov/pubmed/17722233
http://dx.doi.org/10.3349/ymj.2007.48.4.619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628045/
https://www.ncbi.nlm.nih.gov/pubmed/17722233
http://dx.doi.org/10.3349/ymj.2007.48.4.619

Ejemplares similares